USIMD logo
  USIMD home USIMD log In Sign Up!
USIMD Life : Your Healthy Living. Click Here!
Welcome, medical contents search February 5, 2016
       USIMD Life
       Medical Supplies
       Calorie Count
       Physician Search
       Message Board
      E-mail Doctor
      E-mail Veterinarian
      Health-O-Matic Meter
      Calorie Count
      Natural Medicine
      Vitamins & Minerals
      Alternative Living
      My Health Chart
      Diseases & Treatments
      Atlas of Diseases
      Sexually Transmitted
      Drug Information
      Illegal Drugs
      Lab & Diagnostic Tests
      Internal Medicine
      Women’s Health
      Eye Disorders
      Skin Disorders
      Mental Health
      Resource Links
      Physician Directory
      Dentist Directory
      Hospital Directory

Diflucan (Fluconazole)

Systemic Anti-infective

Anti-fungal agent

Vaginal, esophageal, urinary, systemic, Yeast Infection, cryptococcal meningitis.

Doses are tablet, suspension, or IV. (Adults) Adjust according to patient response. Vaginal Yeast Infection: Single 150 mg tablet. Other Yeast Infections: 200mg on 1st day, followed by 100 mg once daily. Continue treatment for >2 weeks. Esophageal Yeast Infection 200 mg on 1st day, followed by 100mg once daily for minimum of 3 weeks. Systemic Yeast Infection: Optimal dosage not established; max. 400 mg/day. UYI, peritonitis: 50 to 200 mg/day. Cryptococcal meningitis: 400 mg on 1st day, followed by 200 to 400 mg once daily. Duration of treatment is 10 to 12 weeks before or after meal.

Category C

Nausea, headache, skin rash, vomiting, abdominal pain, diarrhea. More frequent in AIDS.

Pregnancy Risk Categories defined:

A: Studies in pregnant women failed to show a risk to the fetus in the first trimester - with no evidence of risk in the later trimesters.

B: Animals studies indicate no adverse effect to the fetus, but there are no adequate, clinical studies in pregnant women.

C: Animal studies have shown an adverse effect on the fetus, but there are no adequate, clinical studies in humans. Despite potential risks, the drug may be useful in pregnant women.

D: There is evidence of risk to the human fetus, but the potential benefits of use in pregnant women may be acceptable, despite potential risks.

X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any potential benefit from using the drug in pregnant women, regardless of trimester.

NR: Not rated (i.e., no information available at this time as to the potential risks or benefits).

If you want your friend to read or know about this article, Click here

medical contents search

Home   |   About Us   |   Contact Us   |   Employment Ad   |   Help

Terms and Conditions under which this service is provided to you. Read our Privacy Policy.
Copyright © 2002 - 2003 USIMD, Inc All right reserved.